AT363197B - Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen - Google Patents

Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen

Info

Publication number
AT363197B
AT363197B AT0691077A AT691077A AT363197B AT 363197 B AT363197 B AT 363197B AT 0691077 A AT0691077 A AT 0691077A AT 691077 A AT691077 A AT 691077A AT 363197 B AT363197 B AT 363197B
Authority
AT
Austria
Prior art keywords
16beta
9alpha
6alpha
11beta
17alpha
Prior art date
Application number
AT0691077A
Other languages
German (de)
English (en)
Other versions
ATA691077A (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to AT0151379A priority Critical patent/AT363203B/de
Priority to AT0151279A priority patent/AT363202B/de
Priority to AT151479A priority patent/AT363204B/de
Publication of ATA691077A publication Critical patent/ATA691077A/de
Application granted granted Critical
Publication of AT363197B publication Critical patent/AT363197B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0691077A 1976-09-29 1977-09-28 Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen AT363197B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT0151379A AT363203B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen 9alpha,21-
AT0151279A AT363202B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden
AT151479A AT363204B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von mehrfach halogenierten steroiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (no) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
ATA691077A ATA691077A (de) 1980-12-15
AT363197B true AT363197B (de) 1981-07-10

Family

ID=19728370

Family Applications (3)

Application Number Title Priority Date Filing Date
AT0691077A AT363197B (de) 1976-09-29 1977-09-28 Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen
AT0151279A AT363202B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden
AT0151379A AT363203B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen 9alpha,21-

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT0151279A AT363202B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen mehrfach halogenierten steroiden
AT0151379A AT363203B (de) 1976-09-29 1979-02-28 Verfahren zur herstellung von neuen 9alpha,21-

Country Status (24)

Country Link
JP (1) JPS5356652A (no)
AT (3) AT363197B (no)
AU (1) AU514200B2 (no)
BE (1) BE859120A (no)
CA (1) CA1101410A (no)
CH (9) CH624967A5 (no)
CY (1) CY1178A (no)
DD (1) DD133150A5 (no)
DE (1) DE2743069C2 (no)
DK (1) DK146017C (no)
ES (1) ES462763A1 (no)
FR (1) FR2366311A1 (no)
GB (1) GB1563638A (no)
HK (1) HK16683A (no)
HU (1) HU175218B (no)
IE (1) IE46047B1 (no)
IL (1) IL53012A (no)
KE (1) KE3258A (no)
LU (1) LU75903A1 (no)
MY (1) MY8400092A (no)
NL (1) NL7710089A (no)
SE (1) SE436751B (no)
SG (1) SG3383G (no)
ZA (1) ZA775800B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
WO1991014700A2 (en) * 1990-03-27 1991-10-03 Schering Corporation PROCESS FOR 9α-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
US7098328B2 (en) 2001-11-29 2006-08-29 Taro Pharmaceutical Industries Limited Method for the preparation of 6α-fluoro corticosteroids
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
WO2016205001A1 (en) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
ATA691077A (de) 1980-12-15
JPS6214557B2 (no) 1987-04-02
CA1101410A (en) 1981-05-19
ATA151379A (de) 1980-12-15
DK146017B (da) 1983-05-24
CH625810A5 (en) 1981-10-15
ATA151279A (de) 1980-12-15
DE2743069A1 (de) 1978-03-30
CH631999A5 (en) 1982-09-15
HK16683A (en) 1983-05-27
BE859120A (fr) 1978-03-28
IL53012A (en) 1982-05-31
DK256977A (da) 1978-03-30
SE7706673L (sv) 1978-03-30
GB1563638A (en) 1980-03-26
CH625809A5 (en) 1981-10-15
CH632521A5 (en) 1982-10-15
KE3258A (en) 1983-03-04
SE436751B (sv) 1985-01-21
CH632279A5 (en) 1982-09-30
HU175218B (hu) 1980-06-28
AU514200B2 (en) 1981-01-29
AT363203B (de) 1981-07-27
SG3383G (en) 1983-09-09
CH625808A5 (en) 1981-10-15
CH624967A5 (en) 1981-08-31
DE2743069C2 (de) 1987-03-05
CH631998A5 (en) 1982-09-15
IL53012A0 (en) 1977-11-30
NL7710089A (nl) 1978-03-31
CY1178A (en) 1983-06-10
MY8400092A (en) 1984-12-31
ZA775800B (en) 1978-08-30
JPS5356652A (en) 1978-05-23
FR2366311A1 (fr) 1978-04-28
IE46047B1 (en) 1983-02-09
LU75903A1 (no) 1978-05-16
AT363202B (de) 1981-07-27
DD133150A5 (de) 1978-12-13
DK146017C (da) 1983-10-24
IE46047L (en) 1978-03-29
CH632000A5 (en) 1982-09-15
AU2914877A (en) 1979-04-05
ES462763A1 (es) 1978-05-16
FR2366311B1 (no) 1982-12-03

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT355571B (de) Verfahren zur herstellung von neuen bis -pyridinium-verbindungen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT357703B (de) Verfahren zur herstellung von neuen 9alpha,21- dihalogen-11beta, 17alfa-dihydroxy-6alfa-fluor- 16alfa-methyl-pregna-1,4-dien-3,20-dion-ver- bindungen
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT367401B (de) Verfahren zur herstellung von neuen 6-hydroxyalkyl-1,4-dihydropyridinverbindungen
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT365611B (de) Verfahren zur herstellung von neuen 17alpha-(3-r2-oxypropyl)-17beta-r1-oxy-4-gonen-onen
AT363197B (de) Verfahren zur herstellung von neuen 9alpha,21-dihalogen-11beta, 17alpha-dihydroxy-6alpha-fluor-16beta-methyl-pregna-1,4-dien-3,20-dion-verbindungen
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT361638B (de) Verfahren zur herstellung von neuen dimeren indoldihydroindoldionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT360647B (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT353989B (de) Verfahren zur herstellung von neuen 11,12- ungesaettigten 9alpha-fluorsteroiden
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT356125B (de) Verfahren zur herstellung von neuen 1-aryloxy- -2,3-epoxypropanen
ATA81179A (de) Verfahren zur herstellung von neuen 9alpha, 21- -dihalogen-11beta, 17alpha-dihydroxy-6alpha- -fluor-16alpha-methyl-pregna-1,4-dien-3-20- -dion-verbindungen
AT351515B (de) Verfahren zur herstellung von neuen polyenver- bindungen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen

Legal Events

Date Code Title Description
ELA Expired due to lapse of time